Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses —————— — Research & development —————— — Operating income 693 M770 M4.79 B1.53 B231 M11.31 B 17.87 B Non-Operating Income, Total -338 M-1.46 B369 M-478 M536 M2.75 B 3.18 B Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses -338 M-1.46 B369 M-478 M536 M2.75 B 3.18 B Unusual income/expense —————— — Pretax income 934 M652 M2.14 B1.38 B191 M1.9 B 5.62 B Equity in earnings 67 M217 M-101 M45 M162 M79 M 185 M Taxes 175 M-34 M266 M479 M1.67 B217 M 2.63 B Non-controlling/minority interest 294 M222 M619 M375 M456 M698 M 2.15 B After tax other income/expense —————— — Net income before discontinued operations 465 M464 M1.26 B523 M-1.94 B989 M 833 M Discontinued operations —————— — Net income 465 M464 M1.26 B523 M-1.94 B989 M 833 M Dilution adjustment 000000 0 Preferred dividends 45 M-39 M36 M35 M35 M36 M 142 M Diluted net income available to common stockholders 420 M503 M1.22 B488 M-1.97 B953 M 691 M Basic earnings per share (Basic EPS) —————— — Diluted earnings per share (Diluted EPS) —————— — Average basic shares outstanding —————— — Diluted shares outstanding —————— — EBITDA 1.41 B811 M4.88 B1.66 B246 M— — EBIT 693 M770 M4.79 B1.53 B231 M11.31 B 17.87 B Cost of revenue 3.15 B3.13 B3.57 B6.01 B3.97 B594 M 14.15 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 41 M41 M83 M132 M15 M24 M 254 M